1174014-05-1
1174014-05-1 structure
- Name: Ublituximab
- Chemical Name: Ublituximab
- CAS Number: 1174014-05-1
- Molecular Formula:
- Molecular Weight:
- Catalog: Research Areas Cancer
- Create Date: 2023-01-15 20:07:58
- Modify Date: 2024-01-05 11:37:28
-
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects[1].
| Name | Ublituximab |
|---|
| Description | Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Ublituximab 经过糖工程改造，具有含低岩藻糖的可结晶片段 (Fc) 区域，可增强抗体依赖性细胞毒性[1]。 |
| References |
| No Any Chemical & Physical Properties |